Universe Pharmaceuticals Inc (UPC) Key Ratios

Stock Card

$4.20

$0.17 (4.22%)

As on 08-Sep-2026 16:00EDT

Market cap

$3 Mln

Revenue (TTM)

$-- Mln

P/E Ratio

P/B Ratio

0.1

Div. Yield

0 %

Key Ratios and Highlights

Growth Score (%)	Quarterly		Annual (TTM)
Particulars	QoQ	YoY	1-Year	3-Years	5-Years
Revenue	--	--	-22.44	-23.66	-10.27
EBIT	--	--	57.11	14.57	-180.46
Net Profit	--	--	57.92	16.46	-186.56
EPS	--	--	26.67	-1,476.82	-195.76
Book Value	--	--	114.99	1,858.35	34.92

Key Ratios (%)	Average		Annual (TTM)
Particulars	3-Years	5-Years	Sep-25	Sep-24	Sep-23
EBIT-Margin	-21.84	-10.83	-19.26	-34.83	-11.43
Net Margin	--	--	--	--	--
Return on equity	-14.03	-6.06	-7.23	-20.53	-14.34
Return on Capital	-12.94	-5.62	-6.62	-19.28	-12.92
Return on Assets	-10.22	-4.25	-5.35	-14.40	-10.92
Debt to Equity (x)	--	--	0.16	--	0.14

Profitability

View Detailed Peer Comparison

ROCE

-6.62

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	-6.62	-19.28	-12.92	-15.37	26.11
Peer Median	--	--	--	--	--

ROE

-7.23

Profit after tax / Average Net worth * 100

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	-7.23	-20.53	-14.34	-16.58	28.39
Peer Median	--	--	--	--	--

ROA

-5.35

Profit after tax / Average Total assets * 100

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	-5.35	-14.40	-10.92	-13.47	22.88
Peer Median	--	--	--	--	--

EBIT Margin

-19.26

Operating profit (EBIT) / Net Sales * 100

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	-19.26	-34.83	-11.43	-17.27	28.66
Peer Median	--	--	--	--	--

Net Margin

-20.56

Net profit / Total Income (Net sales plus other income) * 100

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	-20.56	-37.90	-19.08	-21.76	23.59
Peer Median	--	--	--	--	--

Growth

View Detailed Peer Comparison

Revenue Growth

-0.22

Year on year growth in net sales

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	-0.22	-0.29	-0.20	-0.16	0.56
Peer Median	--	--	--	--	--

EBIT Growth

57.11

Year on year growth in operating profit (EBIT)

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	57.11	-117.18	46.73	-150.42	34.77
Peer Median	--	--	--	--	--

Net Profit Growth

57.92

Year on year growth in profit after tax

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	57.92	-41.61	29.46	-177.18	49.77
Peer Median	--	--	--	--	--

EPS Growth

0.27

Year on year growth in earnings per share

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	0.27	-0.37	-2,599.54	-1.77	-1.00
Peer Median	--	--	--	--	--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.16

Total debt / Net worth

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	0.16	--	0.14	0.08	0.07
Peer Median	--	--	--	--	--

Short term debt to equity ratio

0.16

(Short term borrowings / Net worth)

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	0.16	--	0.14	0.08	0.07
Peer Median	--	--	--	--	--

Current Ratio

4.07

Current Assets / Current Liabilities and Provisions

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	4.07	2.54	2.68	3.17	4.50
Peer Median	--	--	--	--	--

Quick Ratio

3.90

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	3.90	2.46	2.43	3.00	4.28
Peer Median	--	--	--	--	--

Interest Coverage

-14.83

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	-14.83	-28.83	-23.55	-42.68	135.32
Peer Median	--	--	--	--	--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

73.84

Debtors outstanding / Net Sales * 100

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	73.84	56.05	33.21	37.82	32.95
Peer Median	--	--	--	--	--

Asset Turnover

0.26

Sales / Average Total Assets

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	0.26	0.38	0.57	0.62	0.97
Peer Median	--	--	--	--	--

Receivable days

266.82

Average Debtors / Sales * 365

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	266.82	187.47	146.47	141.01	101.56
Peer Median	--	--	--	--	--

Inventory Days

62.10

Average Inventory / Sales * 365

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	62.10	54.73	46.08	46.72	35.22
Peer Median	--	--	--	--	--

Payable days

104.04

Average Creditors / Cost of goods sold * 365

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	104.04	102.34	63.61	83.91	64.50
Peer Median	--	--	--	--	--

Cash Conversion Cycle

224.88

Receivable Days + Inventory Days - Payable Days

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	224.88	139.86	128.95	103.81	72.27
Peer Median	--	--	--	--	--

Valuation

View Detailed Peer Comparison

Price / Earnings

0.00

Current share price divided by earning per share in the last twelve months

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	0.00	0.00	0.00	-1.41	4.75
Peer Median	--	--	--	--	--

Price / Book Value

0.00

Current share price divided by book value per share in the latest financial year

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	0.00	0.00	0.00	0.26	0.91
Peer Median	--	--	--	--	--

EV/EBITDA

8.32

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name	Sep-25	Sep-24	Sep-23	Sep-22	Sep-21
Universe Pharmaceuticals Inc (UPC)	8.32	--	4.09	0.41	2.55
Peer Median	--	--	--	--	--

Annual
Quarterly